These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31161507)

  • 1. Site-Specific Antibody-Drug Conjugation Using Microbial Transglutaminase.
    Dickgiesser S; Deweid L; Kellner R; Kolmar H; Rasche N
    Methods Mol Biol; 2019; 2012():135-149. PubMed ID: 31161507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of High Molecular Weight Size Variant Formation in Antibody-Drug Conjugates: Microbial Transglutaminase-Mediated Crosslinking.
    Zhao Y; Kim S; Zheng X; Kim SH; Han A; Chen TH; Wang S; Zhong J; Qiu H; Li N
    J Pharm Sci; 2023 Oct; 112(10):2629-2636. PubMed ID: 37586591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase-Mediated Conjugations.
    Anami Y; Tsuchikama K
    Methods Mol Biol; 2020; 2078():71-82. PubMed ID: 31643050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridged Cysteine Conjugations.
    Bird M; Nunes J; Frigerio M
    Methods Mol Biol; 2020; 2078():113-129. PubMed ID: 31643053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in transglutaminase-mediated assembly of antibody-drug conjugates.
    Schneider H; Deweid L; Avrutina O; Kolmar H
    Anal Biochem; 2020 Apr; 595():113615. PubMed ID: 32035039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs.
    Behrens CR; Ha EH; Chinn LL; Bowers S; Probst G; Fitch-Bruhns M; Monteon J; Valdiosera A; Bermudez A; Liao-Chan S; Wong T; Melnick J; Theunissen JW; Flory MR; Houser D; Venstrom K; Levashova Z; Sauer P; Migone TS; van der Horst EH; Halcomb RL; Jackson DY
    Mol Pharm; 2015 Nov; 12(11):3986-98. PubMed ID: 26393951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Conjugation Site and Technique on the Stability and Pharmacokinetics of Antibody-Drug Conjugates.
    Kaempffe A; Dickgiesser S; Rasche N; Paoletti A; Bertotti E; De Salve I; Sirtori FR; Kellner R; Könning D; Hecht S; Anderl J; Kolmar H; Schröter C
    J Pharm Sci; 2021 Dec; 110(12):3776-3785. PubMed ID: 34363839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates.
    Jackson D; Atkinson J; Guevara CI; Zhang C; Kery V; Moon SJ; Virata C; Yang P; Lowe C; Pinkstaff J; Cho H; Knudsen N; Manibusan A; Tian F; Sun Y; Lu Y; Sellers A; Jia XC; Joseph I; Anand B; Morrison K; Pereira DS; Stover D
    PLoS One; 2014; 9(1):e83865. PubMed ID: 24454709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Production of Homogeneous Lysine-Based Antibody Conjugates Using Microbial Transglutaminase.
    Spidel JL; Albone EF
    Methods Mol Biol; 2019; 2033():53-65. PubMed ID: 31332747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-Specific Conjugation to Native and Engineered Lysines in Human Immunoglobulins by Microbial Transglutaminase.
    Spidel JL; Vaessen B; Albone EF; Cheng X; Verdi A; Kline JB
    Bioconjug Chem; 2017 Sep; 28(9):2471-2484. PubMed ID: 28820579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic conjugation using branched linkers for constructing homogeneous antibody-drug conjugates with high potency.
    Anami Y; Xiong W; Gui X; Deng M; Zhang CC; Zhang N; An Z; Tsuchikama K
    Org Biomol Chem; 2017 Jul; 15(26):5635-5642. PubMed ID: 28649690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K; Ito Y
    Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
    Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
    J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status: Site-Specific Antibody Drug Conjugates.
    Schumacher D; Hackenberger CP; Leonhardt H; Helma J
    J Clin Immunol; 2016 May; 36 Suppl 1():100-7. PubMed ID: 27003914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Site-Specific Antibody-Drug Conjugation by Engineering a Nature-Derived Recognition Tag for Microbial Transglutaminase.
    Ebenig A; Juettner NE; Deweid L; Avrutina O; Fuchsbauer HL; Kolmar H
    Chembiochem; 2019 Sep; 20(18):2411-2419. PubMed ID: 31044494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Drug Conjugation and Loading on Target Antigen Binding and Cytotoxicity in Cysteine Antibody-Drug Conjugates.
    Nadkarni DV; Lee J; Jiang Q; Patel V; Sriskanda V; Dutta K; Meyer DM
    Mol Pharm; 2021 Mar; 18(3):889-897. PubMed ID: 33470823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometric characterization of transglutaminase based site-specific antibody-drug conjugates.
    Farias SE; Strop P; Delaria K; Galindo Casas M; Dorywalska M; Shelton DL; Pons J; Rajpal A
    Bioconjug Chem; 2014 Feb; 25(2):240-50. PubMed ID: 24359082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring Activity and Selectivity of Microbial Transglutaminase.
    Deweid L; Avrutina O; Kolmar H
    Methods Mol Biol; 2019; 2012():151-169. PubMed ID: 31161508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugates.
    Dennler P; Chiotellis A; Fischer E; Brégeon D; Belmant C; Gauthier L; Lhospice F; Romagne F; Schibli R
    Bioconjug Chem; 2014 Mar; 25(3):569-78. PubMed ID: 24483299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-Specific Conjugation of Native Antibodies Using Engineered Microbial Transglutaminases.
    Dickgiesser S; Rieker M; Mueller-Pompalla D; Schröter C; Tonillo J; Warszawski S; Raab-Westphal S; Kühn S; Knehans T; Könning D; Dotterweich J; Betz UAK; Anderl J; Hecht S; Rasche N
    Bioconjug Chem; 2020 Apr; 31(4):1070-1076. PubMed ID: 32134638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.